Population balance modeling: current status and future prospects

D Ramkrishna, MR Singh - Annual review of chemical and …, 2014 - annualreviews.org
Population balance modeling is undergoing phenomenal growth in its applications, and this
growth is accompanied by multifarious reviews. This review aims to fortify the model's …

Diagnostic and Therapeutic Issues in Glioma Using Imaging Data: The Challenge of Numerical Twinning

R Guillevin, M Naudin, P Fayolle, C Giraud… - Journal of Clinical …, 2023 - mdpi.com
Glial tumors represent the leading etiology of primary brain tumors. Their particularities lie in
(i) their location in a highly functional organ that is difficult to access surgically, including for …

Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells

SS Hamed, RM Straubinger, WJ Jusko - Cancer chemotherapy and …, 2013 - Springer
Purpose The standard of care for treating patients with pancreatic adenocarcinomas
includes gemcitabine (2′, 2′-difluorodeoxycytidine). Gemcitabine primarily elicits its …

Pharmacodynamic modeling of cell cycle effects for gemcitabine and trabectedin combinations in pancreatic cancer cells

X Miao, G Koch, S Ait-Oudhia… - Frontiers in …, 2016 - frontiersin.org
Combinations of gemcitabine and trabectedin exert modest synergistic cytotoxic effects on
two pancreatic cancer cell lines. Here, systems pharmacodynamic (PD) models that …

Design of optimal patient-specific chemotherapy protocols for the treatment of acute myeloid leukemia (AML)

E Pefani, N Panoskaltsis, A Mantalaris… - Computers & chemical …, 2013 - Elsevier
AML is a cancer of the blood and bone marrow which results from the combined effects of
genetic mutations, aberrant interactions in the microenvironment and altered networks of …

A mathematical model of subpopulation kinetics for the deconvolution of leukaemia heterogeneity

M Fuentes-Garí, R Misener… - Journal of the …, 2015 - royalsocietypublishing.org
Acute myeloid leukaemia is characterized by marked inter-and intra-patient heterogeneity,
the identification of which is critical for the design of personalized treatments. Heterogeneity …

Identification of age‐structured models: cell cycle phase transitions

E Sherer, E Tocce, RE Hannemann… - Biotechnology and …, 2008 - Wiley Online Library
A methodology is developed that determines age‐specific transition rates between cell cycle
phases during balanced growth by utilizing age‐structured population balance equations …

Towards better combination regimens of cytarabine and FLT3 inhibitors in acute myeloid leukemia

M Elmeliegy, J Den Haese, C Talati, M Wetzler… - Cancer chemotherapy …, 2020 - Springer
Background AML patients with FLT3/ITD mutations have poor response to cytarabine-based
chemotherapy. FLT3 inhibitors (FLT3i) may resensitize cells to cytarabine (CYT). Improving …

Exposure time independent summary statistics for assessment of drug dependent cell line growth inhibition

S Falgreen, MB Laursen, JS Bødker, MK Kjeldsen… - BMC …, 2014 - Springer
Background In vitro generated dose-response curves of human cancer cell lines are widely
used to develop new therapeutics. The curves are summarised by simplified statistics that …

Selecting a differential equation cell cycle model for simulating leukemia treatment

M Fuentes-Gari, R Misener… - Industrial & …, 2015 - ACS Publications
This work studies three differential equation models of the leukemia cell cycle: a population
balance model (PBM) using intracellular protein expression levels as state variables …